Oncolytic viruses get a boost with first FDA-approval recommendation
Elie Dolgin • June 1, 2015
The future of cancer-killing viruses lies in their potential to augment cell and antibody immunotherapies.
Continue reading here.
A closer listen to lion calls may help map where the big cat is under threat.
Scientists remain split on whether rope-pulling ingenuity counts as tool use.